![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1321930
¼¼°èÀÇ ¾ó±¼¿ë ÁÖ»çÁ¦ ½ÃÀå - ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : À¯Çüº°(º¸Åø¸®´® Åå½Å, Äݶó°Õ), ¿ëµµº°(ÁÖ¸§ °³¼±, ¾È¸é ¼ºÇü), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)) : »ê¾÷ ¿¹Ãø(2023-2030³â)Global Facial Injectables Market Size, Share, Growth Analysis, By Type(Botulinum Toxin, Collagen), By Application(Wrinkle Reduction, Facelift), By End-User(Hospitals, Ambulatory Surgery Centers) - Industry Forecast 2023-2030 |
¾ó±¼¿ë ÁÖ»çÁ¦ ½ÃÀå ±Ô¸ð´Â 2021³â 161¾ï ´Þ·¯, 2022³â 175¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È 9.1%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 344¾ï 9,000¸¸ ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ¾ó±¼¿ë ÁÖ»çÁ¦ ½ÃÀåÀº Àþ¾î º¸ÀÌ·Á´Â ¿å±¸ Áõ°¡¿Í ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÇǺΠÇÊ·¯¿Í º¸Åø¸®´® Åå½ÅÀ» Æ÷ÇÔÇÑ ¾ó±¼¿ë ÁÖ»çÁ¦´Â ÁÖ¸§À» ÁÙÀ̰í, ÀÔ¼úÀ» ´Ã¸®°í, ¾ó±¼ À±°ûÀ» ¸¸µå´Â µ¥ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ±â¼ú ¹ßÀü, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ¹ÌÀû °¨°¢ÀÇ È®ÀåÀ¸·Î ÀÎÇØ Ȱ¼ºÈµÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °í·ÉÈ Àα¸ Áõ°¡´Â ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ȯ°æ ¿À¿° ¹°Áú°ú ´Ù¾çÇÑ ¶óÀÌÇÁ ½ºÅ¸ÀÏ ¼±ÅÃÀÌ ÇǺΠ°Ç°¿¡ ¹ÌÄ¡´Â À¯ÇØÇÑ ¿µÇâÀ¸·Î ÀÎÇØ ¾ó±¼¿ë ÁÖ»çÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ÁÖ»ç´Â Äݶó°Õ ¼¶À¯, È÷¾Ë·ç·Ð»ê ÇÊ·¯, ÇÕ¼º ÇÊ·¯·Î ±¸¼ºµË´Ï´Ù.
±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦, Á¦Ç° »ç¿ë Á¦ÇÑ, ¹ßÁø ¹× ¹ßÀû°ú °°Àº ÇǺΠ¹®Á¦ ¹ß»ýÀ¸·Î ÀÎÇØ ½ÃÀå È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¹°Àº ƯÈ÷ ¹Ì¿ë ºÐ¾ß¿¡¼ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀÇ µÎµå·¯Áø Ãß¼¼´Â ³²¼ºµé »çÀÌ¿¡¼ ¾ó±¼¿ë ÁÖ»çÁ¦ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ³²¼ºµéÀº º¸Åø¸®´® Åå½Å°ú ÇǺΠÇÊ·¯¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÇÊ·¯¸¦ Á¡Á¡ ´õ ¸¹ÀÌ ¹Þ¾ÆµéÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ÀþÀº ³²¼ºµéÀº ³ëÈ ¹æÁö¸¦ À§ÇÑ ¼ö´ÜÀ¸·Î Á¶Á÷ ÇÊ·¯¸¦ ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ³²¼ºµé »çÀÌ¿¡¼ ¾ó±¼¿ë ÁÖ»çÁ¦ÀÇ ¼ö¿ëµµ°¡ ³ô¾ÆÁö´Â °ÍÀÌ »ç¿ë·® Áõ°¡¿¡ ±â¿©ÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°èÀÇ ¾ó±¼¿ë ÁÖ»çÁ¦(Facial Injectables) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² À¯Çüº°/¿ëµµº°/ÃÖÁ¾»ç¿ëÀÚº°/Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
Facial Injectables Market size was valued at USD 16.1 billion in 2021 and is poised to grow from USD 17.56 billion in 2022 to USD 34.49 billion by 2030, growing at a CAGR of 9.1% in the forecast period (2023-2030).
The global facial injectables market is experiencing significant growth, driven by factors such as the increasing desire for youthful appearance and rising awareness of aesthetic treatments. Facial injectables, including dermal fillers and botulinum toxin, are widely used for wrinkle reduction, lip augmentation, and facial contouring. The market is fueled by advancements in technology, growing disposable income, and expanding aesthetic consciousness. Rising demand for minimally invasive procedures and the growing aging population are expected to further drive the market's growth in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of Facial Injectables and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
The global facial injectables market is segmented based on type, application, end-user, and region. Based on type, the facial injectables market is segmented as botulinum toxin, collagen, hyaluronic acid, calcium hydroxyl apatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, others. Based on application, the facial injectables market is segmented as wrinkle reduction, facelift, acne scar therapy, lip augmentation, lipoatrophy treatment, others. Based on end-users, the market is segmented as hospitals and ambulatory surgery centers, dermatology and cosmetic clinics, and others. Based on region, the facial injectables market segmentation spans North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
During the projected period, the demand for facial injectables is expected to increase due to the detrimental effects of environmental pollutants and diverse lifestyle choices on skin health. These injectables consist of collagen fibers, hyaluronic acid fillers, and synthetic fillers..
Restrain
However, the expansion of the market is hindered by stringent regulations, limitations on product usage, and the occurrence of skin issues such as rashes and redness. These obstacles impede the market's growth, particularly in terms of aesthetic applications
Trend
A notable trend in the market is the growing adoption of facial injectables among men. Over the forecast period, it is expected that men will increasingly embrace various fillers, including botulinum toxin and dermal fillers. For example, younger men are choosing tissue fillers as a means to combat aging. This increasing acceptance of facial injectables among the male population is likely to contribute to their higher usage.